In a bold move, the China Chamber of Commerce to the EU expressed serious concern over an EU decision that bars Chinese firms from bidding on high-value public tenders in the medical device sector. The new measures, targeting contracts worth over €5M for a five-year period, have sparked a lively debate in global trade circles. 😮
The Chamber argued that the policy contradicts the EU's stated principles of openness, fairness, and non-discrimination. They pointed out that while European medical device companies have long enjoyed robust access to the Chinese market, such selective restrictions create an imbalanced playing field. ⚖️
Warning against rising protectionism, the chamber stressed that using the International Procurement Instrument (IPI) as a de facto trade barrier could disrupt China-EU economic relations and undermine global recovery efforts. The call for a balanced approach reflects the need for mutual benefit and fair play in international trade. 🤝
Urging EU policymakers to reassess the long-term impacts of these measures, the Chamber emphasized that Chinese firms have consistently operated in compliance with laws while contributing investments, technological advancement, and job creation. As the situation unfolds, business communities and young entrepreneurs alike are watching closely, hoping for a fair resolution that fosters innovation and growth. 🚀
Reference(s):
China chamber decries EU discriminatory curbs on medical device firms
cgtn.com
